SpringerLink
Log in

Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy

  • LETTER TO THE EDITORS
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (France)

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yoshikawa N, Tanaka R, Iijima K (2001) Pathophysiology and treatment of IgA nephropathy in children [review]. Pediatr Nephrol 16:446–457

    Article  CAS  PubMed  Google Scholar 

  2. Russo D, Pisani A, Balletta MM, DeNicola L, Savino FA, Andreucci M, Minutolo R (1999) Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy. Am J Kidney Dis 33:851–856

    Article  CAS  PubMed  Google Scholar 

  3. Russo D, Minutolo R, Pisani A, Esposito R, Signoriello G, Andreucci M, Balletta MM (2001) Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. Am J Kidney Dis 38:18–25

    Article  CAS  PubMed  Google Scholar 

  4. Peterson JC, Adler S, Burkart JM, Greene T, Hebert LA, Hunsicker LG, King AJ, Klahr S, Massry SG, Seifter JL (1995) Blood pressure control, proteinuria, and the progression of renal disease. The modification of diet in renal disease study. Ann Intern Med 123:754–762

    Article  CAS  PubMed  Google Scholar 

  5. Cattran DC, Greenwood C, Ritchie S (1994) Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy. Am J Kidney Dis 23:247–254

    CAS  PubMed  Google Scholar 

  6. Mento PF, Wilkes BM (1987) Plasma angiotensins and blood pressure during converting enzyme inhibition. Hypertension 9:III42–48

    Article  CAS  PubMed  Google Scholar 

  7. Biollaz J, Brunner HR, Gavras I, Waeber B, Gavras H (1982) Antihypertensive therapy with MK 421: angiotensin II-renin relationships to evaluate efficacy of converting enzyme blockade. J Cardiovasc Pharmacol 4:966–972

    Article  CAS  PubMed  Google Scholar 

  8. Urata H, Boehm KD, Philip A, Kinoshita A, Gabrovsek J, Bumpus FM, Husain A (1993) Cellular localization and regional distribution of an angiotensin II-forming chymase in the heart. J Clin Invest 91:1269–1281

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  9. Phillips MI, Speakman EA, Kimura B (1993) Levels of angiotensin and molecular biology of the tissue renin angiotensin systems. Regul Pept 43:1–20

    Article  CAS  PubMed  Google Scholar 

  10. Tune BM, Kirpekar R, Sibley RK, Reznik VM, Griswold WR, Mendoza SA (1995) Intravenous methylprednisolone and oral alkylating agent therapy of prednisone-resistant pediatric focal segmental glomerulosclerosis: a long-term follow-up. Clin Nephrol 43:84–88

    CAS  PubMed  Google Scholar 

  11. Yoshikawa N, Ito H, Sakai T, Takekoshi Y, Honda M, Awazu M, Ito K, Iitaka K, Koitabashi Y, Yamaoka K, Nakagawa K, Nakamura H, Matsuyama S, Seino Y, Takeda N, Hattori S, Ninomiya M (1999) A controlled trial of combined therapy for newly diagnosed severe childhood IgA nephropathy. The Japanese Pediatric IgA Nephropathy Treatment Study Group. J Am Soc Nephrol 10:101–109

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Division of Nephrology, Children’s Hospital of Eastern Ontario, University of Ottawa, 401 Smyth Road, Ottawa, Ontario, K1H 8L1, Canada

    Guido Filler & Rakesh Bhattacharjee

Authors
  1. Guido Filler
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rakesh Bhattacharjee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Guido Filler.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Filler, G., Bhattacharjee, R. Additive antiproteinuric effect of ACE inhibitor and losartan in IgA nephropathy. Pediatr Nephrol 17, 302–304 (2002). https://doi.org/10.1007/s00467-002-0829-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-002-0829-y

Search

Navigation